Omada Health is a health technology company focused on digital programs for chronic conditions, combining virtual care delivery, behavioral science, and data analytics.
Founded in 2011 in San Francisco by CEO Sean Duffy, and co-founders Adrian James and Andrew DiMichele, the company began with programs focused on diabetes prevention and weight management. At the time of its launch, digital health remained an emerging field with limited long-term evidence at scale. Over time, their offerings expanded into cardiometabolic care, obesity management, behavioral health, hypertension, and musculoskeletal (MSK) conditions.
A digital platform for better health
Omada Health’s digital platform integrates connected health devices with personalized coaching. Members use tools like smart scales and activity trackers to generate continuous health data, which is analyzed through machine learning systems and reviewed by a clinical team to deliver real-time, individualized feedback. This is paired with structured lessons and peer support groups designed to reinforce behavior change, improve engagement, and support long-term habit formation for chronic disease risk reduction.
Combining GLP-1 and support
The company’s GLP-1–related programs extend this model by combining medication support with behavioral coaching. In its Enhanced GLP-1 Care Track, Omada Health reports that members using GLP-1 therapies alongside its digital care program experience improved medication persistence and better weight-related outcomes compared to medication use without structured behavioral support.
In November 2025, Omada announced plans to expand into GLP-1 prescribing and medication management. It plans to launch nationwide prescribing services in 2026 through licensed providers, combining medication access with its digital coaching program for obesity care. The company also reports outcomes showing greater fat loss and improved body composition, including reduced lean muscle loss, among participants enrolled in the combined care model, highlighting the role of integrated coaching in supporting treatment effectiveness.
Omada’s journey from unicorn status to IPO debut
In June 2025, Omada launched its IPO, raising $150 million. Prior to going public, the virtual care provider reached unicorn status in 2022 following a $192 million Series E funding round led by Fidelity Management & Research Company, with participation from aMoon, Perceptive Advisors, Wellington Management, Civilization Ventures, and other investors.
Omada Health: Patenting Activity
Currently, Omada only has seven active patents and patent applications. Although few in number, these assets reinforce its business model and competitive edge in the digital chronic care market.
| Publication Number | Title | Priority Date | Filing Date |
| US10902741 | Exercise feedback system for musculoskeletal exercises | 2018-03-21 | 2018-03-21 |
| US10922997 | Customizing content for musculoskeletal exercise feedback | 2018-03-21 | 2018-03-21 |
| US11183079 | Augmented reality guided musculoskeletal exercises | 2018-03-21 | 2018-03-21 |
| US11557215 | Classification of musculoskeletal form using machine learning model | 2018-08-07 | 2018-08-07 |
| US20240404079 | Virtual point specification in domain specific language for monitoring user movements | 2023-06-01 | 2023-06-01 |
| US20240404102 | Domain specific language based applications for monitoring user movements | 2023-06-01 | 2023-06-01 |
| US12411660 | Stable point determination for monitoring user movements | 2023-06-01 | 2023-06-01 |
In 2018, Omada Health began research and development in musculoskeletal (MSK) care, including work reflected in multiple active patents focused on virtual physical therapy and the use of machine learning in guided exercise programs. By 2020, the company formally launched its MSK program, expanding its digital care platform to address chronic pain and mobility issues, and also acquired Physera to strengthen its virtual physical therapy capabilities.
In 2021, Omada launched its Insights Lab to analyze clinical and behavioral data across its chronic care programs, generate AI-driven insights, and evaluate outcomes at scale. The platform has since been developed further with enhanced movement tracking and monitoring capabilities, aligning with later patent activity focused on improving digital assessment and feedback in musculoskeletal care.
Omada Health: Top Technology Areas
About 44% of Omada’s filings fall under the G16H classification, which relates to healthcare informatics and medical data processing. This reflects the company’s emphasis on using clinical and behavioral data to support its digital care programs. Around 17% of filings are classified under G06F, indicating a focus on computing systems and digital tools that support its coaching and care delivery platform.
Other significant technologies include educational or demonstration appliances (G09B), diagnosis, surgery, identification (A61B) information and communication technology (G06Q). These assets boost the platform’s data analysis to tailor fit insights for the healthcare program.
Protecting innovation in digital health
Omada Health’s patents safeguard its healthcare coaching, remote monitoring, and behavioral intervention technologies. Following its IPO filing, we examine some of these assets that enhance investor confidence and reinforce the company’s competitive advantage.
Integrating AR and machine learning in exercise therapy
U.S. Patent No. 10,922,997 describes an exercise feedback system that uses remote monitoring, AI-based ranking, and AR guidance to provide personalized, real-time evaluation of musculoskeletal exercise form outside clinical settings.
Currently, individuals rely on in-person therapists or generic digital resources that lack continuous, personalized feedback, making it difficult to ensure proper form and consistent progress. This limits accessibility and reduces adherence to exercise programs.
The disclosed system addresses these gaps by enabling remote trainers to review user performance through captured images, prioritize users using model-based ranking, and deliver targeted feedback. In addition, AR overlays guide correct form in real time, while integrated assessments and surveys enhance personalization and improve ongoing exercise outcomes.
The patent, titled “Customizing content for musculoskeletal exercise feedback,” was filed on March 21, 2018, and granted on February 16, 2021.
AI for exercise form checking
Building on this innovation, U.S. Patent No. 11,557,215, focuses on automated posture and form assessment. The system leverages a machine learning model trained on labeled exercise images to distinguish proper from improper musculoskeletal form.
By processing image or video data from client devices, it delivers real-time corrective or confirmatory feedback, enabling objective, personalized physical therapy without manual supervision. The patent, titled “Classification of musculoskeletal form using machine learning model,” was filed on August 7, 2018, and granted on January 17, 2023.
The ‘997 and ‘215 patents list Yigal Dan Rubinstein, Cameron Marlow, Todd Riley Norwood, Jonathan Chang, Shane Ahern, and Daniel Matthew Merl as inventors.
Advanced body movement tracking and measurement system
U.S. Pat. App. Pub. No. 2024/0404079 discloses a system that uses a domain-specific language (DSL) to generate applications capable of capturing and computing movement-based body measurements from images, enabling structured and customizable analysis for expert review.
Conventional approaches require manual development of measurement tools and offer limited flexibility in defining custom movement assessments, unlike prior systems focused mainly on feedback delivery or automated evaluation. This restricts adaptability across diverse use cases and user needs.
The disclosed technology addresses this by allowing developers or experts to define measurement workflows using DSL commands, which are compiled into executable applications. It also improves accuracy through virtual and stable points derived from body landmarks, enabling consistent and precise measurements across varying motion conditions.
The patent application, titled “Virtual point specification in domain specific language for monitoring user movements,” was filed on June 1, 2023, and was published on December 5, 2024. The application lists Alexander Floyd Prinsen and Brandon Piechowski as inventors.
Fenwick & West LLP provided the legal representation for all the featured patents.
*Image from media center.